Area of research
Radiology, Nuclear Medicine and Imaging · Molecular Biology
Research interest
Research interests include Cardiac Imaging and Diagnostics, Amyloidosis: Diagnosis, Treatment, Outcomes, Cardiovascular Function and Risk Factors, and Parathyroid Disorders and Treatments.
The Last Decade in Cardiac Amyloidosis
Established and Emerging Fluorine-18–Labeled Cardiac PET Radiotracers
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis
Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy
Myocardial Blood Flow Assessment and Reporting for Ischemic Heart Disease
AI-based identification of patients who benefit from revascularization: a multicenter study
Reassessing Cardiovascular Risk in Patients With Peripheral Artery Disease Undergoing Myocardial Perfusion Imaging
Risk stratification with pre-operative myocardial perfusion imaging
Prognostic Value of Left Ventricular 18F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis
Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain Amyloidosis
The Updated Registry of Fast Myocardial Perfusion Imaging with Next-Generation SPECT (REFINE SPECT 2.0)
American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imaging
Functional Status and Quality of Life in Light-Chain Amyloidosis
The Updated REgistry of Fast Myocardial Perfusion Imaging With NExt Generation SPECT
Automating Revascularization Decision Support: Clinical Application of Artificial Intelligence
Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the European Society of Cardiology
Accuracy and Reproducibility of Myocardial Blood Flow Quantification by Single Photon Emission Computed Tomography Imaging in Patients With Known or Suspected Coronary Artery Disease
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis
Coronary Flow Reserve, Inflammation, and Myocardial Strain
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging
International Impact of COVID-19 on the Diagnosis of Heart Disease
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate Utilization
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy
Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis